Literature DB >> 98975

Review of marketed medicinal products: review procedures in Finland and Norway.

J Idänpään-Heikkilä.   

Abstract

Mesh：

Year:  1978        PMID： 98975     DOI： 10.1007/bf01968662

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  8 in total

1.  Possible teratogenicity of imipramine-chloropyramine.

Authors:  J Idänpään-Heikkilä; L Saxén
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

2.  Assessment of therapeutic equivalence in drug registration and control.

Authors:  J Idänpään-Heikkilä
Journal:  Ann Clin Res       Date:  1974

3.  Reserpine use in relation to breast cancer.

Authors:  O P Heinonen; S Shapiro; L Tuominen; M I Turunen
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

4.  Anticonvulsants and parental epilepsy in the development of birth defects.

Authors:  S Shapiro; S C Hartz; V Siskind; A A Mitchell; D Slone; L Rosenberg; R R Monson; O P Heinonen
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

5.  Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland.

Authors:  A Aromaa; M Hakama; T Hakulinen; E Saxén; L Teppo; J Idä lan-Heikkilä
Journal:  Int J Cancer       Date:  1976-12-15       Impact factor: 7.396

6.  Nitrofurantoin-induced acute, subacute and chronic pulmonary reactions.

Authors:  A R Sovijärvi; M Lemola; B Stenius; J Idänpään-Heikkilä
Journal:  Scand J Respir Dis       Date:  1977

7.  Clozapine-induced agranulocytosis: a situation report up to August 1976.

Authors:  B Anderman; R W Griffith
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

8.  Agranulocytosis during treatment with chlozapine.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I P Palva
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.